A recent study conducted by the National Alliance of Mental Illness has found that symptoms of mental illness may worsen during the holiday season. Participants who were part of the study who suffered from various mental health conditions admitted that their conditions worsened during the holiday season.
Pamela Mairs, a licensed psychologist who was part of the study, stated that the coronavirus pandemic had on its own triggered increased mental health conditions in adults. She explained that hopelessness, fear about the future, anxiety, withdrawal and depression had been observed in adults.
The CDC recently released a guide for the holiday season, highlighting the importance of limiting the number of individuals and households gathered together. In the guide, the Centers for Disease Control and Prevention discussed ways to navigate invitations of unvaccinated and vaccinated family members for gatherings during this season. The center also recommended that masks be worn by family members who weren’t fully vaccinated against the coronavirus.
However, national data shows that most individuals will not heed this recommendation. For example, a poll conducted by the Wexner Medical Center at the Ohio State University that involved more than 2,000 participants found that only about 50% of hosts planned to ask their guests to wear masks. This number is a significant decrease from the 67% recorded at the height of the pandemic in 2020. Half of the 50% also revealed that they wouldn’t ask their guests whether they have been vaccinated.
Mairs called attention to the fact that pandemic fatigue was real, which was why individuals needed to ensure that their mental health was a top priority.
The CDC recommends that people avoid indoor spaces, which are highly crowded and/or have poor ventilation, this Thanksgiving season and as we move into the festive season. It highly recommends that individuals who are sick not attend any gatherings, noting that testing to confirm that one does not have the coronavirus prior to travel is crucial.
With regard to travelling, the CDC recommends that people only travel if necessary, adding that those who plan to travel should wear masks on public transportation and follow global travel recommendations.
Individuals with conditions that weaken their immune system are also advised to wear masks because they may not be afforded complete protection even if they are vaccinated and have received a booster shot. In addition, the guideline explicitly states that children aged two years and younger do not need to wear masks.
Experts worry that mental health disorders could escalate due to the impact of the pandemic, and this expected increase makes it even more urgent to come up with new treatments, including those being developed by psychedelics companies such as Cybin Inc. (NYSE American: CYBN) (NEO: CYBN).
NOTE TO INVESTORS: The latest news and updates relating to Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) are available in the company’s newsroom at https://ibn.fm/CYBN
About BioMedWire
BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.
To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
For more information, please visit https://www.biomedwire.com
Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer
BioMedWire (BMW)
San Francisco, California
www.biomedwire.com
415.949.5050 Office
Editor@BioMedWire.com
BioMedWire is part of the InvestorBrandNetwork.
Designations granted by leading global regulatory agencies play a critical role in advancing drug-development programs.…
Enormous resources are being channeled into studying different ways to support the immune system in its fight…
Recent research shows how chemotherapy and immunotherapy can complement each other when used together. Within…
David Eby, the Premier of British Columbia, has revealed that a wide range of American healthcare workers,…
Patients increasingly prefer access, speed and convenience, but healthcare systems also need better coordination, safer…
High-quality development platforms and translational research frameworks have become essential tools in rare-disease biotechnology. Soligenix…